Thromb Haemost 2002; 87(06): 1078-1079
DOI: 10.1055/s-0037-1613137
Letters to the Editor
Schattauer GmbH

Moderate Hyperhomocysteinemia and Central Retinal Vein Occlusion

Armando D’Angelo
1   Coagulation Service and Thrombosis Research Unit, Milano, Italy
,
Alessandra Tavola
2   Department of Ophthalmology and Visual Sciences, Milano, Italy
,
Isabella Fermo
3   Department of Laboratory Medicine, IRCCS H. S. Raffaele, Milano, Italy
,
Giuseppina Mazzola
1   Coagulation Service and Thrombosis Research Unit, Milano, Italy
,
Rosario Brancato
2   Department of Ophthalmology and Visual Sciences, Milano, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 30. November 2001

Accepted 24. Februar 2002

Publikationsdatum:
08. Dezember 2017 (online)

 

 
  • References

  • 1 Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001; 86: 772-6.
  • 2 Fermo I, Vigano’ D'Angelo S, Paroni R, Mazzola G, Calori G, D’Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial thrombosis. Ann Intern Med 1995; 123: 747-53.
  • 3 Fermo I, Arcelloni C, Mazzola G, D’Angelo A, Paroni R. High-performance liquid chromatographic method for measuring total plasma homocysteine levels. J Chromatogr B Biomed Sci Appl 1998; 719: 31-6.
  • 4 de Franchis R, Fermo I, Mazzola G, Sebastio G, Di Minno G, Coppola A, Buoniconti A, Andria G, D’Angelo A. A common mutation of the cystathionine β-synthase gene (844ins68) is a risk factor for early-onset venous and arterial occlusive disease and a determinant of fasting hyperhomocysteinemia only when associated to the thermolabile variant of methylenetetra-hydrofolate reductase. Thromb Haemost 2000; 84: 576-82.